Fixed-dose combination pharmacologic therapy to improve hypertension control worldwide: Clinical perspective and policy implications

J Clin Hypertens (Greenwich). 2019 Jan;21(1):4-15. doi: 10.1111/jch.13426. Epub 2018 Nov 27.

Donald J DiPette¹, Jamario Skeete^{1

2}, Emily Ridley², Norm R C Campbell³, Patricio Lopez-Jaramillo^{4

5}, Sandeep P Kishore^{6

7}, Marc G Jaffe^{8

9}, Antonio Coca¹⁰, Raymond R Townsend¹¹, Pedro Ordunez¹²

¹ University of South Carolina School of Medicine, University of South Carolina, Columbia, South Carolina.
² Palmetto Health, Columbia, South Carolina.
³ Department of Medicine, Physiology and Pharmacology and Community Health Sciences, O'Brien Institute for Public Health and Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada.
⁴ FOSCAL, UDES, Bucaramanga, Colombia.
⁵ Eugenio Espejo Medical Sciences Faculty, UTE, Quito, Ecuador.
⁶ Arnhold Institute for Global Health, Icahn School of Medicine at Mount Sinai, New York, New York.
⁷ Young Professionals Chronic Disease Network, New York, New York.
⁸ Resolve to Save Lives, New York, New York.
⁹ Kaiser Permanente South, San Francisco Medical Center South, San Francisco, California.
¹⁰ University of Barcelona, Barcelona, Spain.
¹¹ Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
¹² Department of Non-Communicable Diseases and Mental Health, The Pan-American Health Organization, Washington, District of Columbia.

No abstract available

Publication types